Biopsies are recommended for new lesions and post-treatment evaluation, with PSMA PET scans used selectively. Here are expert answers to common questions about a prostate cancer experience, ...

Pluvicto™ utilizes a high affinity targeting ligand to direct potent radiotherapy to prostate cancer cells. The specific targeting of this ... releases an energetic beta particle to precisely deliver ...

Nadir prostate ... cancer. Ray et al. attempted to determine the importance of these parameters as predictors of biochemical and distant recurrence in 4,833 patients who were treated with external ...

When it comes to managing prostate cancer, there is no one-size-fits-all approach. Men must consider a variety of factors ...

Men undergoing treatment for prostate cancer could be safely given far less ... be released at the American Society for Therapeutic Radiation and Oncology (Astro) conference in San Diego.

Early evidence suggests that stereotactic radiation therapy appears to be as effective, less onerous and less invasive than ...

177Lu-PSMA-I&T therapy improved radiographic progression-free survival in metastatic castration-resistant prostate cancer patients. The ECLIPSE trial compared 177Lu-PSMA-I&T with hormone therapy, ...

An Israeli medical breakthrough could cut in half the number of radiation treatments needed for prostate cancer patients.